Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Lyra Therapeutics (LYRA)

Annual Return

Over the past 3 years, LYRA has had an average annual return of -85.08%, underperforming the benchmark SPY, which returned +19.63% annual.

Over the past 5 years, LYRA has had an average annual return of -72.53%, underperforming the benchmark SPY, which returned +12.73% annual.

Since May 1, 2020, LYRA has had an average annual return of -69.63%, underperforming the benchmark SPY, which returned +18.57% annual.

2026202520242023202220212020
-81.82%-70.27%-96.07%+66.84%-27.97%-61.76%-38.58%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-42.42%-42.11%-54.55%+60%+0%-12.50%-14.29%-81.82%
2025-11.71%+17.35%-40.87%-5.88%-17.19%+83.02%-25.77%+4.17%-6.67%-11.43%-35.48%-17.50%-70.27%
2024-13.14%+15.58%+18.24%-17.04%-93.63%-15.82%+17.45%-1.14%-20.23%+7.25%-24.32%-0.89%-96.07%
2023-9.22%-16.54%-15.52%+19.39%+7.12%+59.86%-21.64%+8.07%+12.37%-24.06%+11.44%+58.33%+66.84%
2022-6.17%+19.06%-17.45%+40.54%-5.29%+5.58%+14.88%-10.78%-13.49%-6.37%-25.17%-10.52%-27.97%
2021-7.28%+41.16%-22.32%-13.11%-28.70%+11.84%-19.81%+10.86%+27.79%-20.00%-23.29%-22.14%-61.76%
2020-14.49%-28.55%+18.17%-2.47%-14.46%-4.30%+16.08%-8.22%-38.58%

Drawdown analysis of Lyra Therapeutics (LYRA)

The maximum drawdown for the LYRA was -99.96%, occurring on Mar 23, 2026. This drawdown has not yet recovered.

The current LYRA drawdown is -99.94%.

Since May 1, 2020 LYRA has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.96%May 1, 20201479Mar 23, 2026OngoingOngoingOngoing